Shattuck Labs, Inc. (STTK)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Taylor H. Schreiber
Employees:
100
1018 W. 11TH STREET, AUSTIN, TX 78703
919-864-2700

Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company was incorporated in 2016 and is headquartered in Austin, Texas.

Data derived from most recent annual or quarterly report
Market Cap 115.462 Million Shares Outstanding42.449 Million Avg 30-day Volume 36.925 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-2.41
Price to Revenue175.982 Debt to Equity0.0 EBITDA-95.942 Million
Price to Book Value0.7914 Operating Margin-14220.592400000001 Enterprise Value-10.724 Million
Current Ratio9.859 EPS Growth-0.693 Quick Ratio8.464
1 Yr BETA 0.9855 52-week High/Low 5.82 / 1.85 Profit Margin-13842.1721
Operating Cash Flow Growth-30.9119 Altman Z-Score0.9594 Free Cash Flow to Firm -80.07 Million
Earnings Report2023-08-10

Are you looking for this stock instead?

View SEC Filings from STTK instead.

View recent insider trading info

Shattuck Labs, Inc. YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding STTK (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding STTK

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2023-05-12 by STOUT STEPHEN
  • 3: filed on 2023-03-31 by STOUT STEPHEN
  • 4: filed on 2023-01-27 by NEILL ANDREW R
  • 4: filed on 2023-01-27 by THOMSON ERIN ATOR
  • 4: filed on 2023-01-27 by SHUKLA ABHINAV A.
  • 4: filed on 2023-01-27 by PANDITE ARUNDATHY N.
  • 4: filed on 2023-01-27 by DEYOUNG CASI
  • 4: filed on 2023-01-27 by SCHREIBER TAYLOR
  • 4: filed on 2023-01-12 by DEYOUNG CASI
  • 4: filed on 2023-01-12 by PANDITE ARUNDATHY N.

    • Events (8k)

  • 8-K: filed on 2023-05-24:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2023-03-10:
    Item 7.01: Regulation FD Disclosure
  • 8-K: filed on 2023-02-23:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-11-08:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-08-11:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-07-29:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-06-10:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2022-05-12:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-03-15:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-11-09:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    STOUT STEPHEN SEE REMARKS

    • Officer
    		 30,875 2023-05-10 2

    SCHREIBER TAYLOR CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    		 165,050 2023-01-25 1

    DEYOUNG CASI CHIEF BUSINESS OFFICER

    • Officer
    		 101,080 2023-01-25 2

    THOMSON ERIN ATOR GENERAL COUNSEL

    • Officer
    		 151,459 2023-01-25 1

    NEILL ANDREW R CHIEF FINANCIAL OFFICER

    • Officer
    		 214,266 2023-01-25 1

    PANDITE ARUNDATHY N. CHIEF MEDICAL OFFICER

    • Officer
    		 245,542 2023-01-25 2

    SHUKLA ABHINAV A. CHIEF TECHNICAL OFFICER

    • Officer
    		 99,292 2023-01-25 2

    REDMILE GROUP, LLC

    GREEN JEREMY

    • Director
    • 10% Owner
    		 40,258 2022-06-08 1

    GIBSON NEIL W

    • Director
    		 40,258 2022-06-08 1

    GOLUMBESKI GEORGE

    • Director
    		 40,258 2022-06-08 1

    BOUDREAU HELEN M

    • Director
    		 40,258 2022-06-08 1

    LEE MICHAEL STEWART

    • Director
    		 40,258 2022-06-08 1

    BROUS TYLER

    • Director
    		 40,258 2022-06-08 1

    BROWNSTEIN CARRIE

    • Director
    		 40,258 2022-06-08 1

    HORNBLOWER JOSIAH

    • Director
    		 3,234,440 2021-07-15 0

    HILL MICHAEL CEO, PRESIDENT

    • Officer
    • Director
    • 10% Owner
    		 766,332,598 2015-04-30 0

    GRAVITZ AARON

    • Director
    • 10% Owner
    		 556,180,583 2015-04-30 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    STOUT STEPHEN - Officer SEE REMARKS

    		2023-05-12 16:11:35 -0400 2023-05-10 A 15,900 a 30,875 direct 1.5326 -0.3831 6.1303 5 -3.2567 3

    STOUT STEPHEN - Officer SEE REMARKS

    		2023-05-12 16:11:35 -0400 2023-05-10 A 31,800 a 31,800 direct

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    SHATTUCK LABS INC STTK 2023-05-29 22:15:04 UTC 2.6157 2.4543 200000
    SHATTUCK LABS INC STTK 2023-05-29 21:45:05 UTC 2.6157 2.4543 200000
    SHATTUCK LABS INC STTK 2023-05-29 21:15:04 UTC 2.6157 2.4543 200000
    SHATTUCK LABS INC STTK 2023-05-29 20:45:04 UTC 2.6157 2.4543 200000
    SHATTUCK LABS INC STTK 2023-05-29 20:15:05 UTC 2.6157 2.4543 200000
    SHATTUCK LABS INC STTK 2023-05-29 19:45:04 UTC 2.6157 2.4543 200000
    SHATTUCK LABS INC STTK 2023-05-29 19:15:04 UTC 2.6157 2.4543 200000
    SHATTUCK LABS INC STTK 2023-05-29 18:45:04 UTC 2.6157 2.4543 200000
    SHATTUCK LABS INC STTK 2023-05-29 18:15:03 UTC 2.6157 2.4543 200000
    SHATTUCK LABS INC STTK 2023-05-29 17:45:04 UTC 2.6157 2.4543 200000
    SHATTUCK LABS INC STTK 2023-05-29 17:15:04 UTC 2.6157 2.4543 200000
    SHATTUCK LABS INC STTK 2023-05-29 16:45:04 UTC 2.6157 2.4543 200000
    SHATTUCK LABS INC STTK 2023-05-29 16:15:03 UTC 2.6157 2.4543 200000
    SHATTUCK LABS INC STTK 2023-05-29 15:45:03 UTC 2.6157 2.4543 200000
    SHATTUCK LABS INC STTK 2023-05-29 15:15:03 UTC 2.6157 2.4543 200000
    SHATTUCK LABS INC STTK 2023-05-29 14:45:05 UTC 2.6157 2.4543 200000
    SHATTUCK LABS INC STTK 2023-05-29 14:15:04 UTC 2.6157 2.4543 200000
    SHATTUCK LABS INC STTK 2023-05-29 13:45:05 UTC 2.6157 2.4543 200000
    SHATTUCK LABS INC STTK 2023-05-29 13:15:03 UTC 2.6157 2.4543 200000
    SHATTUCK LABS INC STTK 2023-05-29 12:45:03 UTC 2.6157 2.4543 200000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments